Topic

Elaine Quilici is a freelance writer for 

Articles

Panelists in a recent roundtable share ideas on transforming company culture, fostering greater patient diversity, and acting on pharma’s fast-evolving social mandate.

Diversity & Inclusion in Pharma: Industry Leaders Bring Conversation to Forefront 

Recent roundtable brought together by Pharm Exec and Parexel features insights from leaders in the pharma industry on the current state and future of RWE.

Real-World Evidence: State-of-the-Art, Current Challenges and Future Vision

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Chief financial officers gather virtually to share the stories of directing their company IPOs over the finish line amid the COVID-19 pandemic.

Going Public During Lockdown: IPO Insights from Five Biotechnology CFOs

A recent roundtable moderated by Rob Jekielek of The Harris Poll gathered five biopharma CEOs to discuss the industry’s shifting reputational landscape in the public eye.

Leadership and Industry Image

A recent roundtable moderated by Dr. Scott Gottlieb gathered biopharma CEOs to share thoughts and strategies on navigating their companies through the COVID-19 outbreak.

Leadership During Pandemic

Pharm Exec sits down with a pair of big pharma compliance leaders to discuss the strategic move to principles-based policies and the impact of other emerging forces influencing industry compliance practice.

Compliance Disruptors

Financial leaders from clinical-stage biopharma gather to discuss the critical role of finance and accounting (F&A) in supporting and sustaining the science at the forefront of engagement with investors.

Science & Finance: The Biotech Blend

Pharm Exec convenes an expert panel at CBI’s Pharmaceutical Compliance Congress to discuss new ways to navigate the many complexities when it comes to the crucial task of assessing business and risk in the life sciences.

Compliance: The Critical Cog in Pharma Machine

Executives from diagnostics, payer, pharma, and patient care companies converge to share the inside scoop on outcomes-based contracting.


Pharma: Meet Your New Neighbors

Facing mixed market signals, biotech companies look to rise above the fray in advancing new-wave discoveries to the clinical finish line.

Executive Roundtable